Enzyme levels and G-463A Polymorphism of Myeloperoxidase in chronic lymphocytic leukemia and multiple myeloma

Leukemia and Lymphoma

Volumn 50, Issue 12, 2009, Pages 2030-2037

  Saygili, Eyup Ilker ^a   Aksoy, Nur ^a   Pehlivan, Mustafa ^a   Sever, Tugce ^a   Yilmaz, Mehmet ^a   Cimenci, Iclal Geyikli ^a   Pehlivan, Sacide ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Gene polymorphism; Leukemia; Multiple myeloma; Myeloperoxidase

Indexed keywords

MYELOPEROXIDASE;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 72949089501     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903244582     Document Type: Article

References (37)

1. Horrobin DF. Is the main problem in free radical damage caused by radiation, oxygen and other toxins, the loss of membrane essential fatty acids rather than the accumulation of toxic materials? Med Hypotheses 1991;35:23-26.
2. Farinati F, Cardin R, Libera CD, Rugge M, Mario FD. Lipid peroxidation and anti-oxidant defense in human gastric mucosa. Gastroenterol Hepatol 1993;5:59-61.
3. Goldstein BD, Czerniceki B, Witz G. The role of free radicals in tumor promotion. Environ Health Perspect 1989;81:55-57.
4. Djurdjevic P, Zelen I, Ristic P, et al. Oxidative stress markers in chronic lymphocytic leukemia. Medicus 2006;7:52-56.
5. Chapman A, Skaff O, Senthilmohan R, Kettle AJ, Davies M. Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. Biochem J 2009;417:773-781.
6. Englert RP, Shacter E. Distinct modes of cell death induced by different reactive oxygen species. J Biol Chem 2002;277: 20518-20526.
7. Pitt AR, Spickett CM. Mass spectrometric analysis of HOCland free-radical-induced damage to lipids and proteins. Biochem Soc Trans 2008;36:1077-1082.
8. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008;112:935-945.
9. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Eng J Med 2003;349:1595-1604.
10. Cascorbi I, Henning S, Brockmöller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant - 463A of the myeloperoxidase gene. Cancer Res 2000;60:644-649.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
12. Mendell NR, Simon GA. A general expression for the variance-covariance matrix of estimates of gene frequency: the effects of departures from Hardy-Weinberg equilibrium. Ann Hum Genet 1984;48:283-286.
13. Malle E, Marsche G, Arnhold J, Davies MJ. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta 2006;1761:392-415.
14. Thukkani AK, Martinson BD, Albert CJ, Vogler GA, Ford DA. Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury. Am J Physiol Heart Circ Physiol 2005; 288:2955-2964.
15. Malle E, Furtmuller PG, Sattler W, Obinger C. Myeloperoxidase: a target for new drug development? Br J Pharmacol 2007;152:838-854.
16. Oberg G, Dahl R, Ellegaard J, Sundström C, Vaeth M, Venge P. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, highlactoferrin AML. Eur J Haematol 1987;38:148-155.
17. Schlaifer D, Duchayne E, Demur C, et al. Vincristine degradation by serum from leukemic patients: role of myeloperoxidase. Leuk Lymphoma 1996;20:441-446.
18. Hoy A, Tregouet D, Leininger-Muller B, et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms, Eur J Hum Genet 2001;9:780-786.
19. Doǧan AA, Doǧzan L, Canpinar H, Demirpençe E. Hidroksiürenin lökositlerin mikrobisid fonksiyonlarina etkileri. Turk J Biochem 2004;29:232-236.
20. Özgen U, Tü rköz Y, Stout M, et al. Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia. Leuk Res 2003;27: 1109-1113.
21. Battisti V, Maders LD, Bagatini MD, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem 2008;41:511-518.
22. Nakazato T, Sagawa M, Yamato K, et al.Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 2007;15:5436-5445.
23. Chen J, McMillan NA. Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia. Cancer Biol Ther 2008;7:174-179.
24. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physic 1999;111:383-389.
25. Hampton MB, Ketle AJ, Winterbourn CC. Inside neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-3017.
26. Abu-Soud HM, Hazen SL. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 2000;275: 5425-5430.
27. Kour H, Perkins MJ. The free radical chemistry of food additives. In: Aruoma OI, Halliwell B, editors. Free radicals and food additives. New York; 1991.
28. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ. A new mechanism of glomerular injury: the myeloperoxidasehydrogenperoxide Halide system. J Clin Invest 1987;79: 1379-1387.
29. Taioli E, Benhamou S, Bouchardy C, et al. Myeloperoxidase G-463 a polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med 2007;9:67-73.
30. Kitahara M, Eyre HJ, Simonian Y, Atkin CL, Hasstedt SJ. Hereditary myeloperoxidase deficiency. Blood 1981;57: 888-893.
31. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001;142:336-339.
32. Wheatley-PP, Asomaning K, Reid A, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 2008;112:1037-1042.
33. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996;271:14412-14420.
34. Zhang J, Zhu YF, Pu YP, et al. Analysis of multiple single nucleotide polymorphisms (SNPS) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Han population. J Toxicol Environ Health A 2007;70:901-907.
35. Reynolds W, Chang E, Douer D. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 1997;90:2730-2737.
36. Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med 2004;116:429-430.
37. Melle I, Ostergaard M, Melsvik D, Guldborg CN. Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms. Leuk Lymphoma 2008;49:1116-1122.